Organization
Pacira Pharmaceuticals
22 clinical trials
Clinical trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis (RANGE)Status: Terminated, Estimated PCD: 2020-06-15
Clinical trial
A Randomized, Open-label Study Comparing the Systemic Exposure to Triamcinolone Acetonide Following a Single Intra-articular Dose of Extended-release FX006 or Immediate-release TAcs (Triamcinolone Acetonide Suspension) in Patients With Osteoarthritis of the Shoulder (Glenohumeral Joint) or HipStatus: Completed, Estimated PCD: 2018-10-09
Clinical trial
A Phase 1, Pilot, Open Label, Study to Evaluate the Pharmacokinetics, and Safety, of EXPAREL Administered as Pectoral Plane Block in Women Undergoing Breast Augmentation SurgeryStatus: Completed, Estimated PCD: 2020-01-15
Clinical trial
A Phase 1, Double-Blind, Active- and Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy VolunteersStatus: Recruiting, Estimated PCD: 2024-07-30
Clinical trial
An Open-Label, Single Ascending Dose Study to Assess the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the KneeStatus: Active (not recruiting), Estimated PCD: 2023-11-28
Clinical trial
An Open-label, Single Administration Study to Characterize the Local Duration of Exposure of Triamcinolone Acetonide From FX006 in Patients With Osteoarthritis (OA) of the KneeStatus: Completed, Estimated PCD: 2014-04-01
Clinical trial
A Randomized, Open-label, Parallel Group Study in Patients With Bilateral Knee Osteoarthritis Comparing the Systemic Exposure of Triamcinolone Acetonide Following Administration Into Both Knees of Either Extended-release FX006 or Immediate-release TAcs (Triamcinolone Acetonide Suspension)Status: Completed, Estimated PCD: 2018-03-14
Clinical trial
A Double-Blind, Randomized,Placebo-Controlled, Two-Phase Study (a Single Ascending Dose Phase Followed by a Proof of Concept Phase) to Assess the Safety, Efficacy and Pharmacokinetics of FX005 for the Treatment of Pain in Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2012-01-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip OsteoarthritisStatus: Terminated, Estimated PCD: 2019-08-07
Clinical trial
A Single-arm, Open-label Study to Evaluate a Procedure for Intra-articular (IA) Injection of FX006 in Patients With Osteoarthritis (OA) of the HipStatus: Completed, Estimated PCD: 2019-10-11
Clinical trial
A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2015-11-01
Clinical trial
An Open-label, Single Administration Study to Characterize the Systemic Pharmacokinetics and Local Extent and Duration of Exposure of Triamcinolone Acetonide From FX006 in Patients With Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2016-09-01
Clinical trial
A Double-Blind, Randomized, Parallel Group, Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the KneeStatus: Terminated, Estimated PCD: 2016-07-01
Clinical trial
An Open-label Study to Assess the Safety of Repeat Administration of FX006 to Patients With Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2018-07-19
Clinical trial
A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2013-04-01
Clinical trial
A Double-Blind, Randomized, Parallel Group Comparison of the Effects of FX006 and TCA IR (Triamcinolone Acetonide Suspension) on Blood Glucose in Patients With Osteoarthritis of the Knee and Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2016-10-01
Clinical trial
A Multicenter, Open-label, Randomized, Bupivacaine-Controlled Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Aged 0 to Less Than 6 Years Undergoing Cardiac SurgeryStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2016-01-01
Clinical trial
An Open-Label Study to Evaluate the Effect of the Administration of FX006 on Synovial Inflammation in Patients With Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2019-11-08
Clinical trial
A Double-Blind, Randomized, Parallel Group, Active Comparator Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects (HPA Axis) of FX006 in Patients With Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2012-11-01
Clinical trial
A Phase 3, Multicenter, Randomized, Double-blind, Single-dose Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects With Glenohumeral OsteoarthritisStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Phase 1, Open-Label Study to Evaluate the Pharmacokinetics and Safety of Local Administration of EXPAREL for Postsurgical Analgesia in Pediatric Subjects 12 to Less Than 17 Years of AgeStatus: Completed, Estimated PCD: 2019-02-12